Detalles de la búsqueda
1.
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.
Lancet Oncol
; 23(2): 304-316, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35051385
2.
A Phase II prospective study of hypofractionated proton therapy of prostate and pelvic lymph nodes: Acute effects on patient-reported quality of life.
Prostate
; 82(14): 1338-1345, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35789497
3.
Impact of adjuvant trastuzumab on locoregional failure rates in a randomized clinical trial: North Central Cancer Treatment Group N9831 (alliance) study.
Cancer
; 126(24): 5239-5246, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32931029
4.
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
N Engl J Med
; 376(5): 417-428, 2017 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28146658
5.
Adjuvant and Salvage Radiotherapy after Prostatectomy: ASTRO/AUA Guideline Amendment 2018-2019.
J Urol
; 202(3): 533-538, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31042111
6.
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.
Lancet Oncol
; 19(11): 1504-1515, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30316827
7.
Proposed prognostic scoring system evaluating risk factors for biochemical recurrence of prostate cancer after salvage radiation therapy.
BJU Int
; 118(2): 236-42, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26190356
8.
Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: the Radiation Therapy Oncology Group [0831] randomized clinical trial.
JAMA
; 311(13): 1300-7, 2014 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-24691606
9.
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial.
Eur Urol
; 85(4): 373-381, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36710205
10.
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.
J Clin Oncol
; : JCO2302445, 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38759121
11.
Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202.
Eur Urol Focus
; 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38307806
12.
Neighborhood Deprivation and Rurality Associated With Patient-Reported Outcomes and Survival in Men With Prostate Cancer in NRG Oncology RTOG 0415.
Int J Radiat Oncol Biol Phys
; 116(1): 39-49, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36736921
13.
Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.
J Clin Oncol
; 41(4): 881-892, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36269935
14.
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.
Int J Radiat Oncol Biol Phys
; 115(3): 645-653, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36179990
15.
Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer.
Prostate
; 72(16): 1757-66, 2012 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22513981
16.
Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526).
Int J Radiat Oncol Biol Phys
; 112(5): 1115-1122, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34740768
17.
Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415.
JCO Clin Cancer Inform
; 6: e2100188, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35776901
18.
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601.
J Clin Oncol
; 40(27): 3172-3179, 2022 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35737923
19.
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.
NPJ Digit Med
; 5(1): 71, 2022 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35676445
20.
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.
JAMA Oncol
; 8(3): e216871, 2022 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35050303